Package 72657-194-11

{"route": ["OPHTHALMIC"], "spl_id": "5ce14b14-b893-4d56-a19e-b1788b17074f", "openfda": {"upc": ["0372657194259"], "unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["07e8b359-d4ae-4b5b-81dc-c7e57e172c58"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BOTTLE, PLASTIC in 1 CARTON (72657-194-11)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "72657-194-11", "marketing_start_date": "20250228"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (72657-194-25)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "72657-194-25", "marketing_start_date": "20250228"}], "brand_name": "OLOPATADINE HYDROCHLORIDE", "product_id": "72657-194_5ce14b14-b893-4d56-a19e-b1788b17074f", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "72657-194", "generic_name": "OLOPATADINE HYDROCHLORIDE", "labeler_name": "GLENMARK THERAPEUTICS INC., USA", "product_type": "HUMAN OTC DRUG", "brand_name_base": "OLOPATADINE HYDROCHLORIDE", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA219557", "marketing_category": "ANDA", "marketing_start_date": "20250228", "listing_expiration_date": "20271231"}